Gudrun C Thurner (Gudrun C Thalhammer-Thurner)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Topics

Dendritic Cells

Papillary Thyroid

Top Venues

Current oncology (Toronto, Ont.)

Nanoscale advances

Histochemistry and cell biology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Gudrun C Thurner, Paul Debbage
Albumin-based nanoparticles: small, uniform and reproducible. Nanoscale advances 5 (2) (2023)
Gudrun C Thurner, Paul Debbage
Albumin-based nanoparticles: small, uniform and reproducible. Nanoscale advances 5 (2) (2023)
Cornelia Speth, Ruben Bellotti, Georg Schäfer, Günter Rambach, Bernhard Texler, Gudrun C Thurner, Dietmar Öfner-Velano, Cornelia Lass-Flörl, Manuel Maglione
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. Current oncology (Toronto, Ont.) 29 (12) (2022)
Cornelia Speth, Ruben Bellotti, Georg Schäfer, Günter Rambach, Bernhard Texler, Gudrun C Thurner, Dietmar Öfner-Velano, Cornelia Lass-Flörl, Manuel Maglione
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. Current oncology (Toronto, Ont.) 29 (12) (2022)
Cornelia Speth, Ruben Bellotti, Georg Schäfer, Günter Rambach, Bernhard Texler, Gudrun C Thurner, Dietmar Öfner-Velano, Cornelia Lass-Flörl, Manuel Maglione
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. Current oncology (Toronto, Ont.) 29 (12) (2022)
Cornelia Speth, Ruben Bellotti, Georg Schäfer, Günter Rambach, Bernhard Texler, Gudrun C Thurner, Dietmar Öfner-Velano, Cornelia Lass-Flörl, Manuel Maglione
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. Current oncology (Toronto, Ont.) 29 (12) (2022)
Cornelia Speth, Ruben Bellotti, Georg Schäfer, Günter Rambach, Bernhard Texler, Gudrun C Thurner, Dietmar Öfner-Velano, Cornelia Lass-Flörl, Manuel Maglione
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. Current oncology (Toronto, Ont.) 29 (12) (2022)
Cornelia Speth, Ruben Bellotti, Georg Schäfer, Günter Rambach, Bernhard Texler, Gudrun C Thurner, Dietmar Öfner-Velano, Cornelia Lass-Flörl, Manuel Maglione
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. Current oncology (Toronto, Ont.) 29 (12) (2022)
Gudrun C Thurner, Johannes Haybaeck, Paul Debbage
Targeting Drug Delivery in the Elderly: Are Nanoparticles an Option for Treating Osteoporosis? International journal of molecular sciences 22 (16) (2021)
Gudrun C Thurner, Paul Debbage
Molecular imaging with nanoparticles: the dwarf actors revisited 10 years later. Histochemistry and cell biology 150 (6) (2018)